What is meat? You might say it's simple: water, fat, muscle, connective tissue you know, all that tasty-sounding stuff.
But those at the forefront of developing cell-cultured meat have a different idea. Maybe meat is the product not of killing animals but of cultural consensus.
At the center of Chase Purdy's briskly paced and quietly bold Billion Dollar Burger: Inside Big Tech's Race for the Future of Food is Josh Tetrick, a San Francisco-based entrepreneur and CEO of Just Inc. Tetrick's company and a handful of others like it are growing cell-cultured meat that tastes, feels and looks like the livestock-harvested meat that people are used to except without the farms and killing of animals. And before anyone raises a skeptical brow: Yes, it's actually meat. Technically, at least. The struggle for mainstream acceptance of cell-cultured meat is real. Convincing the American public that cells grown in "serum" in a big vat is meat will be challenging, but it could happen and sooner than you might think.
Meat, it seems, is all about what consumers are used to. For the sake of the planet and the future of food sustainability, it might be time to reconsider meat harvested from dead animals. If we're going to eat meat at all, eliminating the need to kill an animal that consumes food resources humans could otherwise be using and that's also captive to an industry that pollutes the air and soil and deforests broad swaths of the planet might be a good start.
One of Purdy's strengths is his ease in exposition. He can even be charmingly teacherlike at times. Take, for instance, how he describes how cell-cultured meat is grown, starting with cells taken from a live animal.
"The scientists at cell-cultured meat companies identify which cells are stem cells. Whereas ordinary cells have limited utility, stem cells can divide and multiply many times, and they can transform into any of the more than two hundred types of cells that operate within animal bodies.
Think of our cells as individuals on a building construction site. Some are assigned to lay cement, some are trained as carpenters, and another might be an electrician. Together, they work harmoniously to build different components of the larger structure. But it is possible to pluck a cement worker from her job, send her to classes where she'll learn about wiring, plugs, and sockets. Then she can be sent back into the field as a newly trained electrician. The same thing can happen on a molecular level."
That's not all though. Scientists grow those cells in a kind of liquid. Because lab-grown meat doesn't have blood to circulate nutrients like living bodies do, scientists at Just and companies like it use a kind of "serum" that contains sugars, lipids, hormones and amino acids, as well as many hundreds of proteins that carry out functions such as transporting insulin, which helps grow cultured vertebrate cells, or transferrin, which delivers iron to cells. Oh, and all this takes place in vats that can look straight out of a brewery.
In covering the business side of cell-cultured meat, Purdy could have written a hagiographic account of Tetrick and Just; refreshingly, he chose not to. This could have been another Steve Jobs-type story no one needs, where a visionary has a great idea that will change the world and then, after the world gets changed wait for it said visionary gets really rich too. Then, as Americans, we're left undecided as to whether we admire the accomplishment or the wealth more. Instead, Purdy's book reads more realistically, like the teasing out of a tangled dance among entrenched meat producers, a few ambitious start-ups, early pioneers, regulatory complications and consumer skepticism.
It's the lack of heroes that, in part, makes this such an interesting story and topic. Tetrick knew from his early years that he cared about animal welfare and that he wanted to do something good for the world. He drifted through law school and still was unsure about a proper course for his life. He decided on cell-cultured meat as a cause and business because he saw opportunity and it aligned with his values and so he decided to take it. And in the depiction of Tetrick, Purdy is careful to allow him to tell his story, as well as capture others' stories of him, some of which are unflattering. Meat, however, stays front and center in this story. It keeps you hungry.
Still, there's the moral and ethical matter of manipulating nature to serve human ends. Sure, other forms of this kind of manipulation go by the names "civilization" or "technology," but the issues arising from cell-cultured meat aren't minor. Essentially it's cloning. Purdy asks Peter Singer, a Princeton University bioethics professor and the author of Animal Liberation, whether growing meat in vats violates the natural order and if he has a problem with it. "No, I don't, to be honest," Singer says. "I think we can and always have striven to do better than nature. ... I don't think nature is in any way a gold standard."
Alice Waters, famous chef of Chez Panisse in Berkeley, Calif., sees things differently. She tells Purdy: "I really think of my food as deeply connected to nature. It has to do with seasonality; it has to do with a complexity of soil that grows the vegetables that the animals eat. I think it's what nourishes us." This might be true, but most people don't (and can't) get their meat locally sourced, even if that would be ideal. Sustainable consumption of meat might just require more cell-cultured meat than its livestock-harvested antecedent.
Purdy rightly leaves the humans vs. nature debate aside, though, after teasing out the positions, and gets back to the big question: What is meat? Philosopher Friedrich Nietzsche wrote that "there is no feast without cruelty," but he clearly did not live to see the still ambiguous but encouraging promise of cell-cultured meat. Meat, oddly enough, might just be what we agree meat is. Heretofore it was the flesh of a dead animal. Now it can be engineered in a lab to have the same properties that a living animal's flesh would have.
If the taste and texture are the same and if the cost is manageable, why not? Now, when someone says, "It tastes like chicken," you can say: "It is chicken." It's grilling without the killing.
Nicholas Cannariato is a writer and editor based in Chicago.
Read the original:
'Billion Dollar Burger' Asks: What Is Meat? - Delaware First Media
- Japan Stem Cells Market to be at Forefront by 2028 - November 24th, 2022
- Mice Model Technologies Market Outlook, Competitive Landscape and Forecasts to 2031 - openPR - October 13th, 2022
- Cell & Tissue Preservation Market Size will Observe Lucrative Surge by the End 2031 - openPR - October 13th, 2022
- PRP and PRF in Cosmetics Market Growth Opportunities Analysis Report - openPR - October 13th, 2022
- Orthobiologics Market to Receive Overwhelming Hike in Revenues by 2031 - openPR - October 13th, 2022
- Stem Cells Market is Expected to Grow with High Probability Business Opportunity by 2028 - Digital Journal - October 4th, 2022
- External Beam Radiation Therapy Market: Growing Awareness about Early Detection and Diagnosis of various Cancer Types to Drive the Market - BioSpace - September 16th, 2022
- DiMethyl Sulfoxide (DMSO) Market to Touch US$ 838.6 Million in 2032 Owing to its Widespread Application in End-Use Industries & Anti-Inflammatory... - September 16th, 2022
- Virology Market Growth Prospects, Trends and Forecast up to 2030 - BioSpace - September 8th, 2022
- Cell Banking Outsourcing Market is Driven by Rising Number of Stem Cell Therapies across the Globe - BioSpace - September 8th, 2022
- Regenerative Therapies Market 2018 By Emerging Trends, Industry Share, Regional Overview and SWOT Analysis till 2026 - Digital Journal - August 22nd, 2022
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends, Competitive Landscape and Regional Insights to 2031 - BioSpace - August 14th, 2022
- Multiphoton Microscopy Market Insights, New Innovations, Research and Growth Factor till 2031 - BioSpace - August 14th, 2022
- Buffalo center fuels research that can save your life from heart disease and stroke - Buffalo News - August 5th, 2022
- Drug Discovery Services Market is Expected to Witness Significant Growth between 20212031 - BioSpace - July 27th, 2022
- Stem Cells Market to Expand at a CAGR of 10.4% from 2021 to 2028 Travel Adventure Cinema - Travel Adventure Cinema - July 27th, 2022
- Dental Membrane and Bone Graft Substitutes Market to Exceed Value of US$ 1,337 Mn by 2031 - PR Newswire UK - July 27th, 2022
- Lipid Disorder Treatment Market is Projected to Experience Promising Growth Opportunities in the Forthcoming Years - BioSpace - July 27th, 2022
- Immunoglobin Products Market to Witness Comprehensive Growth by 2031 - BioSpace - July 19th, 2022
- Antibody Therapy Market Propels at a Robust CAGR of 13.2% due to Rising Cancer and Other Chronic Disease Prevalence Future Market Insights, Inc. -... - July 19th, 2022
- Orthobiologics Market is Predicted to Expand at a CAGR of 4.7% during the Forecast Period, notes TMR Study - GlobeNewswire - July 11th, 2022
- Cell Line Development Market: Increase in Prevalence of Cancer and Other Chronic Diseases to Drive the Market - BioSpace - July 11th, 2022
- Transplant Diagnostic Market: Increase in Number of Cancer & Blood Disorder Patients to Drive the Market - BioSpace - July 11th, 2022
- Microscopy Devices Market Competitive Insights and Precise Outlook 2021-2028 Industrial IT - Industrial IT - June 4th, 2022
- Neoantigen Targeted Therapies Market Analysis and Opportunity Assessment up to 2027 - BioSpace - June 4th, 2022
- Why Eraser Enzymes Go Wrong and Lead to Cancer - SciTechDaily - December 10th, 2021
- MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of... - August 31st, 2021
- Incyte and MorphoSys Announce the European Commission Approval of Minjuvi (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults... - August 31st, 2021
- Rock snot discovered in another Pennsylvania waterway - pennlive.com - September 12th, 2020
- Bone Marrow and Stem Cell Transplants ChristianaCare - June 20th, 2020
- Data from Incytes Oncology Portfolio Accepted for Presentation at the ASCO and EHA Virtual Meetings - Yahoo Finance - May 20th, 2020
- Stem Cell therapy Middletown Delaware 19709 - February 10th, 2020
- First CAR-T cell cancer therapy patient in Delaware - Dover Post - February 10th, 2020
- Gore, Mayo Clinic team up to deliver breakthrough medical therapies - Plastics Today - December 17th, 2019
- Global Stem Cell Therapy Market 2019-2025 Analyzed by Business Growth, Development Factors, Applications, and Future Prospects - Technology Magazine - December 17th, 2019
- From inspiration to innovation | UDaily - UDaily - November 14th, 2019
- What Will Happen to Actinium Pharmaceuticals Inc (delaware (NYSEAMERICAN:ATNM) Next? The Stock Has Increase in Shorts - The Lamp News - October 26th, 2019
- Could Fate Therapeutics, Inc. (FATE) Recover After Forming a Bearish Head & Shoulders Pattern? - The Altcoin Mercury - September 25th, 2019
- Stem Cell therapy Lewes Delaware 19958 - September 14th, 2019
- Westfield High School Principal Derrick Nelson was 'gift ... - May 16th, 2019
- SignalRx - March 22nd, 2019
- Stem Cell therapy Newark Delaware 19725 - February 27th, 2019
- Stem Cell therapy Wilmington Delaware 19810 - February 27th, 2019
- Stem Cell Therapy | Regenerative Delaware - February 22nd, 2019
- Regenerative Cell Treatment &Therapy - Delaware ... - February 22nd, 2019
- Stem Cell Doctors Delaware, Stem cell injections, Stem ... - October 14th, 2018
- Regenerative Cell Therapy - Delaware Integrative Medicine - June 22nd, 2018
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - Delaware First Media - August 30th, 2017
- Detroit Lions' Paul Worrilow has beaten odds, inspires others to help - Detroit Free Press - July 2nd, 2017
- Lions LB Paul Worrilow Making A Difference On And Off The Field - FanRag Sports (blog) - July 2nd, 2017
- Lions LB Paul Worrilow gave stem cells to anonymous leukemia patient - Detroit Free Press - March 11th, 2017
- Delaware (Stem Cell) - what-when-how - November 3rd, 2016
- University of Delaware Chemical Engineering - October 31st, 2015
- Home | www.papoutsakis.org - October 4th, 2015
- Stem Cells - Eppendorf - October 2nd, 2015
- Efficient Differentiation of Mouse Embryonic Stem Cells ... - October 1st, 2015
- Alpine Rose Leaf Extract for Environmental Protection for ... - October 1st, 2015
- De-Differentiation of Somatic Cells to a Pluripotent State ... - June 29th, 2015
- DSU AgDiscovery 2015 - Investing in the Future of American ... - June 1st, 2015
- Stem-cell battles: Stem-cell research in the USA is facing ... - April 9th, 2015
- IPS Stem Cells: New Ethical Quandaries - Santa Clara ... - December 27th, 2014
- The California Cloning and Stem Cell Laws - December 27th, 2014
- Can a bodys own stem cells help heal a heart? - October 19th, 2014
- Delaware Stem Cell Treatment | Stem Cell Treatments - September 9th, 2014
- Core mechanism for root growth identified - August 25th, 2014
- Stem Cell Companies - A Comprehensive Overview - August 23rd, 2014
- Stem Cell Doctors, Physician Team, Our Doctors - August 23rd, 2014
- California Stem Cell Report: California Stem Cell Agency ... - August 23rd, 2014
- Bone Marrow and Stem Cell Transplants - Christiana Care ... - August 22nd, 2014